Approval · Notice of Compliance 1445 · 2000
RANITIDINE TABLETS: Notice of Compliance 1445
Issued May 17, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1445
- Date
- May 17, 2000
- Company
- Fc Pharma Inc.Scarborough, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Histamine h2 receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RANITIDINE TABLETS | 02242056 | — |
| RANITIDINE TABLETS | 02242057 | — |
| RANITIDINE TABLETS | 02242058 | — |
Medicinal ingredients
- RANITIDINE HCL 75 MG per TAB
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 300 MG per TAB